7 Oct 2013 08:39
7 October 2013
TYRATECH, INC.
("TyraTech" or the "Company")
Director/PDMR Shareholding
The Company received notification on 4 October 2013 that, Alan Reade, Non-Executive Chairman of the Company, purchased on that date 675,000 common shares of US$0.001 in the Company ("Common Shares") at a price of 5 pence per share. 227,000 of the Common Shares purchased were purchased in Alan Reade's wife's name.
Following this transaction, Alan Reade is beneficially interested in 10,486,358 Common Shares representing an interest of 6.25 per cent of the total voting rights of the Company. In addition, Alan Reade is interested in 2,645,695 stock appreciation right options over Common Shares as follows:
Options Held | Option Exercise Price | Expiry Date |
1,000,000 | 6p | 25 April 2022 |
100,570 | 12p | 6 March 2022 |
550,000 | 10.5p | 4 February 2020 |
995,125 | 12p | 20 October 2020 |
For further information please contact:
TyraTech Inc.Alan Reade, Non-Executive ChairmanTel: +44 7841 978 709
Bruno Jactel, Chief Executive Officer
Tel: +1 919 415 4340
N+1 Singer, Nominated Adviser and Joint BrokerJonny Franklin-Adams / Alex WrightTel: +44 20 7496 3000
First Columbus LLP, Joint BrokerChris CrawfordTel: +44 20 3002 2070
Walbrook, Financial PR and IR
Bob Huxford /Guy McDougall (Public Relations)
Tel + 44 7933 8792
Paul Cornelius (Investor Relations)
Tel +44 20 7933 8794